Call Us 24x7
Founded in March 2014 by a group of returned oversea doctors and located in the High-tech Zone of Gaomi City, Shandong Province, Bellastem Biotechnology Limited（BBL） now stands as a state-level hi-tech enterprise providing biotech services of tumor biotherapy, R&D and clinical application of stem cells as well as genetic detection http://kop-viagra.net/kop-cialis-pa-natet .
BBL has a high-level talent team with solid professional skills, which has 1 external academician, 7 external doctor’s degree holders,5 doctor’s degree holders，15 master’s degree bearer and nearly 100 bachelor’s degree or above possessor. With all the equipment imported from abroad and a complete quality control system required by GMP, BBL has built a 3000㎡-sized, 10K, partly hundred level sterile and modernized immune cell lab which has reached international advanced level and accords with the standard of FDA, GMP and Good manufacture practice for sterile medical devices (YY0033-2000). The company has established Weifang Stem Cell and Immunotherapy Engineering Technology Research Center, Weifang Key Laboratory of Cellular and Genetic Engineering and Weifang Genetic Disease Genetic Testing Engineering Research Center. Particularly, BBL established the first, also the only Med Lab in the city of Weifang, which has medical examination and practice qualifications in specialities of clinical immunology, serology and clinical cellular molecular genetics, etc.
Always holds “the world’s leading medical technology for China ” as its mission and to provide high-end medical technology services for all patients in China, BBL conducts active and deep cooperation with other trusted scientific research and medical institutions at home and abroad, focusing on R&D and application of life sciences and cutting-edge biomedical technology, facilitates transformation of scientific research achievement, strongly promotes industrialization of R&D, production and sales of series products of stem cells and cell culture medium and continuously improves the level of biological cell immunotherapy.
Recently, Shandong Provincial Development and Reform Commission issued the " Notice on the List of newly certified Engineering Research Centers in Shandong Province in 2021". the Shandong Engineering Research Center for Genetic Disease Genetic Detection established by Bellastem Biotechnology Ltd. was successfully selected. This shows that Shandong Provincial Development and Reform Commission has affirmed Bellastem's innovation ability and research and development strength in the field of genetic disease genetic testing. Shandong Provincial Engineering Research Center is established by Shandong Provincial Development and Reform Commission in accordance with the strategic needs of strengthening the province through science and education and building a modern economic system, with...
Mid-Autumn Festival, is the time of the gentle love.The moon is particularly bright at the Mid-Autumn Festival,the sky is high, and the air is clear and fragrant.Such a beautiful time,reuniting with our families,is the loveliest poetic and pictorial splendor at this festival. To show the ritual of the Mid-Autumn Festival,Nothing is more desirable than a gift. Bellastem carefully selected elegant moon cakes for everyone to convey the true care, bear good wishes. A moon cake with a piece of love,The golden crust is studded with autumn light,Mellow taste knead into the long yearning,The round and soft shape blends in the fullness of the gathering. People in strange lands,You can also use the memory of yo...
On August 24, the Shandong division of the 11th China Innovation and Entrepreneurship Competition , Action Plan of Shandong Provincial Micro, Small and Medium-sized Enterprise Innovation Competition (biomedical field) in 2022 ,were held in Jining high-tech zone. Bellastem Biotechnology Ltd. won the Winning Enterprise Award in the growth group of biomedical field in this competition. China Innovation and Entrepreneurship Competition is a brand competition with the highest level, the largest scale, the most extensive radiation and the most powerful influence in the field of science and technology in China. With the theme of " lead in innovation, build entrepreneurship dreams", the competition set up seven strategic emerging industries, including new generation information techno...
On the afternoon of September 5th, the Biomedical Science and Technology Innovation Forum of Overseas Chinese Returnees Innovation and Entrepreneurship Summit, Weifang, Shandong,China, co-sponsored by the Science and Technology Bureau of Weifang High-Tech Zone, Western Returned Scholars Association and Shandong Institute of Somatic Cell Industrial Technology( a wholly-owned subsiduary of BBL), was held in Weifang Fuhua Hotel. ...
On June 6, 2023, Bellastem Biotechnology Co., LTD. (hereinafter referred to as BBL") self-developed biological products "Xinbang Mesenchymal Stem Cell Injection" clinical trial registration (IND) Approved by NMPA (acceptance number :CXSL2300213), It marks a milestone breakthrough in the field of stem cell drug research and development. "Xinbang Mesenchymal Stem Cell Injection" is the first product of BBL that got clinical trial registration. It took 6 years to develop, and it’s indication is KOA. The repair and regeneration properties of stem cells open up a new path for the treatment of KOA. Through paracrine and immunomodulatory mechanisms, the drug can repair the cartilage, bone, ligament and connective tissue of th...
Bellastem Biotechnology Co., Ltd. was listed as Innovative S&M Enterprises of Shandong Province" in 2022 by Department of Industry and Information Technology of Shandong Province. According to the standard and Implementation Rules for innovative S&M enterprises in Shandong Province, innovative S&M enterprises refer to those with high specialization level, strong innovation ability, development potential, and influential enterprise in the field of industry segmentation, is the recognition for the innovation ability of the enterprise. The selection of Bellastem indicating that our professional ability, innovation ability and future development potential was highly recognized by the Departm...
